Times in bold are shown as Greenwich Mean Time (GMT).
11:00 |
Opening address & Poster session |
11:15 12:15 (CET) 06:15 (EST) 03:15 (PST) |
Harnessing the power of tumor organoids: Next-gen drug screening with live-cell imaging Dr. Christophe Deben, Assistant Experimental Oncology, Centre for Oncological Research, University of Antwerp |
12:00 13:00 (CET) 07:00 (EST) 04:00 (PST) |
Precision oncology in practice: The path to clinical utility Dr. Ofer Sharon, CEO, OncoHost |
12:45 13:45 (CET) 07:45 (EST) 04:45 (PST) |
ADME: The building block to successful drug discovery Samer Sansil, Scientist, Moffitt Cancer Centre |
13:30 14:30 (CET) 08:30 (EST) 05:30 (PST) |
Analytical considerations for cfDNA biomarker analysis powered by NGS Krishna Amin, Senior Global Product Manager, Targeted & Enterprise Genomics & Dr. Leif Schauser, Director, Product Management, Genome Analysis, QIAGEN |
14:15 15:15 (CET) 09:15 (EST) 06:15 (PST) |
Focus on the key players: Surveying the proteome with high-density antibody panels Dr. Valerie Sloane Jones, Director, Marketing and Technical Support, RayBiotech, Inc. |
15:00 16:00 (CET) 10:00 (EST) 07:00 (PST) |
Molecular changes in dense breast tissue Prof. Noelle Cutter, Associate Professor, Molloy College |
15:45 16:45 (CET) 10:45 (EST) 07:45 (PST) |
Advancing precision oncology with a portfolio of tumor genomic profiling solutions Akanksha Khare, Senior Scientist, R&D, Agilent Technologies |
16:30 17:30 (CET) 11:30 (EST) 08:30 (PST) |
Solutions for culturing, maintaining and characterizing induced pluripotent stem cells Dr. Daryl Cole, Scientist, Sartorius |
17:15 18:15 (CET) 12:15 (EST) 09:15 (PST) |
Breakthrough research advances early detection in colorectal cancer |
18:00 19:00 (CET) 13:00 (EST) 10:00 (PST) |
Harnessing the power of ddPCR to advance precision oncology |
18:45 19:45 (CET) 13:45 (EST) 10:45 (PST) |
Advantages of new AI-based stain-free cell analysis for cancer research |